Resolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review

Fenfluramine is a medication originally approved for weight loss before being withdrawn for an association with the development of pulmonary arterial hypertension (PAH) and cardiac valvulopathy. Interest in fenfluramine at lower doses has re-emerged for treatment of drug-resistant epilepsy (DRE). He...

Description complète

Détails bibliographiques

Auteurs principaux:	Rebecca Strafella, Richard Wang, Marissa Petchpradub, Ariel Sacknovitz, Patricia E. McGoldrick, Steven M. Wolf
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2024-01-01
Collection:	Epilepsy & Behavior Reports
Sujets:	Drug-resistant epilepsy LGS Lennox-Gastaut Syndrome Fintepla
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S258998642400087X
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!